Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	59.62B -64.4%
Revenue (ttm)	30.69B +9.5%
Net Income	-4.06B
EPS	-455.61
Shares Out	8.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,611
Open	6,980.00
Previous Close	6,980.00
Day's Range	6,690.00 - 7,180.00
52-Week Range	6,620.00 - 18,470.00
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was incorporated in 2006 and is based in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2025, Raphas's revenue was 30.99 billion, an increase of 13.86% compared to the previous year's 27.22 billion. Losses were -4.31 billion, -9.58% less than in 2024.